CAMP and autoimmune disease: Pathology attributed to LL-37 in autoimmune diseases includes a feed-forward pathway of inflammatory signaling wherein pre-existing LL-37 autoantibodies form immune complexes (ICs) with LL-37 discharged by activated neutrophils as components of NETs.6